Table 1.
Staging |
Restaging |
|||
Pro | Cons | Pro | Cons | |
ERUS | High accuracy and specificity for early rectal cancer (T) | Tends to overstage N | High accuracy for persistent lymph nodal involvement | Low accuracy for T restage |
Operator dependent | ||||
Long learning curve | ||||
MRI | Ability to evaluate CRM | Low accuracy for lymph-nodes involvement | Good prediction for CRM involvement | Poor accuracy in predicting ypT0 and ypN0 |
Best tool to select patients for neoadjuvant treatment | ||||
High accuracy in advanced tumors | ||||
PET | Confirmation of M and N at distant sites | Low accuracy for T staging | Detection of progression at distant sites | Lack of standardization of the criteria used to assess the response |
MRI: Magnetic resonance imaging; ERUS: Endorectal ultrasound; PET: Positron emission tomography; CRM: Circumferential margin.